Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Needs Assessment for Bereaved Families (NABF)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Herzog Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Joint Distribution Committee (JDC)
Information provided by:
Herzog Hospital
ClinicalTrials.gov Identifier:
NCT00447252
First received: March 13, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose

The present study will focus on several objectives in the framework of the family perspective and systemic understanding of the mourning process:

  1. Identification of the psychological, social and practical needs of families that have lost a child to terrorism.
  2. Deepening and extending the knowledge of how families cope with the loss of a child in a violent incident of a security-related nature.
  3. Identification of risk and resilience factors within the family structure, and the nature of the relationships within the family.

Condition Phase
Bereaved Families
Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Needs Assessment for Bereaved Families

Further study details as provided by Herzog Hospital:

Estimated Enrollment: 100
Study Start Date: January 2007
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   2 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • lost a son or daughter below the age of 18 as a result of a terrorist incident,
  • at least six months previously

Exclusion Criteria:

  • single-parent families
  • family members who suffer from mental retardation, disturbances because of addiction, or psychiatric disturbance from the psychotic or autistic spectra (schizophrenia, manic-depressive illness, psychotic disturbances, PDD).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00447252

Locations
Israel
The Israel Center for the Treatment of Psychotrauma
Jerusalem, Israel
Sponsors and Collaborators
Herzog Hospital
Joint Distribution Committee (JDC)
Investigators
Study Director: Danny Brom, Ph.D The Israel Center for the Treatment of Psychotrauma
  More Information

ClinicalTrials.gov Identifier: NCT00447252     History of Changes
Other Study ID Numbers: Brom2CTIL 
Study First Received: March 13, 2007
Last Updated: March 13, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Herzog Hospital:
bereavement
grief

ClinicalTrials.gov processed this record on December 09, 2016